
GICELL Announces the Preclinical Research Data Demonstrating the Superiority of the NK Cell Mass Culture Platform at the Society for Immunotherapy of Cancer
– Data supporting high expression of activation and tumor targeting markers of NK cells mass cultured without feeder cells – Proved the excellent anti-tumor efficacy […]














